Market Size and Growth
As per the Advanced Genomics Market size analysis conducted by the CMI team, the global advanced genomics market is expected to record a CAGR of 16.21% from 2025 to 2034. In 2025, the market size was USD 48.31 Billion. by 2034, the valuation is anticipated to reach USD 186.70 Billion.
Overview
As per the industry experts at CMI, the global advanced genomics market will witness a stellar CAGR between 2025 and 2034. This could be due to advancements with respect to DNA sequencing technologies, a rise in demand for personalized medicine, growing government ’funding regarding genomics research, and expansion in applications of genomics in several fields such as agriculture and drug discovery. Innovations pertaining to long-read technologies are improving the efficiency and precision of genomic analysis further.
Key Trends & Drivers
- Growing Awareness and Adoption of Next-generation Sequencing to Determine Growth: Rise in awareness amongst the public regarding genomics’ potential is accelerating the demand for genetic services and services related to them. Use of NGS technologies at a larger scale in clinical and research settings is fueling the market further. NGS has been reported to drastically reduce time and cost linked with DNA sequencing, thereby rendering it more accessible for research applications.
- Personalized Medicines to rule the Roost: Personalized development plans are coming into being due to the ability of advanced genomics to analyze the genetic makeup of an individual, thereby resulting in more targeted and effective therapies. Comprehending the genetic basis of the diseases facilitates preventive measures due to early diagnosis.
Report Scope
| Feature of the Report | Details |
| Market Size in 2025 | USD 48.31 Billion |
| Projected Market Size in 2034 | USD 186.70 Billion |
| Market Size in 2024 | USD 41.57 Billion |
| CAGR Growth Rate | 16.21% CAGR |
| Base Year | 2024 |
| Forecast Period | 2025-2034 |
| Key Segment | By Offering, Technology, Application, End-user and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
SWOT Analysis
- Strengths: NGS and various other advanced technologies have noticeably enhanced the speed, raised the precision level, and rendered cost-effectiveness regarding genomic analysis. The best part is that the status quo is expected to remain the same going forward. Moreover, ongoing research is continuously expanding knowledge regarding gene function and the role played by it in disease, thereby resulting in new therapeutic and diagnostic possibilities. These, apart from the call for personalized medicines, are the strengths of the advanced genomics market.
- Weaknesses: Higher cost of genomic sequencing as well as analysis could be prohibitive for certain institutions and individuals, thereby limiting adoption far and wide. Also, analysis and interpretation of genomic data need specialized bioinformatics tools, which could prove to be a barrier to certain entrants. In certain cases, reimbursing the expenses incurred during genomic services and testing may not be possible. This could also be one of the weaknesses.
- Opportunities: Advanced genomics does offer unprecedented opportunities for identifying genetic causes of the rare diseases, which are leading to precise diagnoses. ML and AI are capable of accelerating data analysis, prediction of diseases in genomics, and drug discovery. Advanced technologies are also making way for novel gene therapies with genome editing techniques, thereby offering cures for genetic diseases.
- Threats: Using genomic information is likely to raise ethical concerns regarding data security, privacy, and potential misuse of the genetic piece of information. Additionally, navigating the complex regulatory landscape for genomic therapies and testing could be challenging for the companies. These could be the threats to advanced genomics market.
List of the prominent players in the Advanced Genomics Market:
- Illumina
- Thermo Fisher Scientific
- Danaher Corporation
- Agilent Technologies Inc.
- QIAGEN
- Oxford Nanopore Technologies
- Pacific Biosciences of California Inc.
- BGI Genomics
- Myriad Genetics Inc.
- Eurofins Scientific
- Hoffmann-LA Roche AG
- Laboratory Corporation of America Holdings
- Revvity
- Luminex Corporation
- Bio Rad Laboratories Inc.
- Others
The Advanced Genomics Market is segmented as follows:
By Offering
- Products
- Services
By Technology
- Sequencing
- PCR
- Gene Editing
- Flow Cytometry
- Microarrays
- In Situ Hybridization
By Application
- Diagnostics
- Drug Discovery and Development
- Precision Medicine
- Agriculture
By End-user
- Hospitals and Clinics
- Research Centers
- Pharmaceutical and Biotechnology Companies
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America